Introduction {#Sec1}
============

*Terminalia* Linn, comprising about 250 species in the world mostly as medium or large trees, is the second largest genus in the family Combretaceae. The name "*Terminalia*" is derived from Latin word "terminus", which means the leaves are located at the tip of the branch. The bark of *Terminalia* plants usually has cracks and branches tucked into layers. Most of the *Terminalia* plants' leaves are large, leathery with solitary or clustered small green white flowers. Their fruits are yellow, dark red or black; drupe, usually angular or winged. Some fruits are edible, highly nutritious and possess medicinal values.

*Terminalia* species are widely distributed in the southern Asia, Himalayas, Madagascar, Australia, and the tropical and subtropical regions of Africa. *Terminalia* plants in southern Asia have been intensively studied phytochemically due to their wide usage in Asian (India, Tibetan, and Chinese) traditional medicine systems \[[@CR1]\]. For example, the fruits of *Terminalia bellirica* and *Terminalia chebula*, together with *Phyllanthus emblica* (Euphorbiaceae) which form the herbal remedy, Triphala, in Tibetan medicine, have received much attention because of its extensive and remarkable effectiveness in the treatment of anticancer, antifungal, antimicrobial, antimalarial, antioxidant.

So far, 39 *Terminalia* species have been investigated for their phytochemical constituents, which resulted in the identification of terpenes, tannins, flavonoids, lignans and simple phenols, amongst others. Pharmacological studies suggest that they have exhibited activity on liver and kidney protection, antibacterial, antiinflammatory, anticancer, and have displayed a positive effect on immune regulation, cardiovascular disease and diabetes, and acceleration of wound healing.

This paper features 39 important medicinal and edible *Terminalia* species and summarizes their traditional usage, geographical distribution, structures of isolated chemical constituents and pharmacological activities.

Species' Description, Distribution and Traditional Uses {#Sec2}
=======================================================

So far, 50 *Terminalia* species have been documented, 39 of which have been reported to possess medicinal properties and/or being edible. Among them, eight species and four varieties including *T. argyrophylla*, *T. bellirica*, *T. catappa*, *T. chebula*, *T. franchetii*, *T. hainanensis*, *T. myriocarpa*, *T. intricate*, *T. chebula* var. *tomentella*, *T. franchetii* var. *membranifolia*, *T. franchetii* var. *glabra*, and *T. myriocarpa* var. *hirsuta* are distributed in China (Yunnan, southeast Tibet, Taiwan, Guangdong, south Guangxi and southwest Sichuan). Their distribution and traditional applications are shown in Table [1](#Tab1){ref-type="table"}.Table 1Local names, distributions and traditional uses of *Terminalia* plantsNo.PlantsLocal namesDistributionsTraditional usesT1*T. alata*UnknownSouthern Vietnam \[[@CR2], [@CR3]\]Anti-diarrhea, ulcer, diuretics, supplements \[[@CR3]\]T2*T. amazonia*White oliveSouthern Costa Rica \[[@CR4]\]WoodT3*T. arborea*Jaha KlingIndonesiaCardiovascular disease, myocardial infarction, atherosclerosis, diabetes, cancer, stroke, cataract, shoulder stiffness, cold allergy, hypertension, senile dementia, inflammation, gum disease (e.g. gingivitis, pneumonia), Alzheimer's, skin conditions \[[@CR5]\]T4*T. arjuna*Arjuna, White Marudah, KohaIndia, South Asia, Sri Lanka \[[@CR6]\]Cardiotonic, sores, bile infection, poison antidote \[[@CR6]\]Coughs, dysentery, fractures, contusions, ulcers, hypertension ischaemic heart diseases \[[@CR23]\]T5*T. argyrophylla*Silver leaves Chebula, Xiao Chebula (Yunnan), Manna (Yunnan Dai language)China (Yunnan) \[[@CR7]\]Autoimmune diseases \[[@CR7]\]T6*T. australis*Tanimbu, palo amarilloPunta Lara, Argentina (Buenos Aires) \[[@CR8]\]HemostasisT7*T. avicennioides*kpayi, Kpace, bausheNigeria \[[@CR9], [@CR10]\]Malaria, worms, gastric peptic ulcer \[[@CR9]\], scorpion bites \[[@CR10]\], tuberculosis, cough \[[@CR90]\]T8*T. bellirica*BelericChina (southern Yunnan), Vietnam, Laos, Thailand, Cambodia, Myanmar, India (except West), Malaysia, IndonesiaLaxative, edibleEdema, diarrhea, leprosy, bile congestion, indigestion, headache \[[@CR11]\]Fever, diarrhea, cough, dysentery, skin diseases \[[@CR12]\]Wine, palm sugar \[[@CR23]\]Diarrhea \[[@CR94]\]T9*T. bentzoe*UnknownRodrigues \[[@CR13]\]Essential oil \[[@CR13]\]T10*T. bialata*Indian silver greywoodIndia, South AsiaWood \[[@CR14]\]T11*T. brachystemma*Kalahari cluster leafSouthern AfricaShistosomiasis, gastrointestinal disorders \[[@CR15]\]T12*T. brownii*kuuku, muvuku (Kamba, Kenya), koloswa (northern region, Kenya), weba (Ethiopia), lbukoi (Samburu, Kenya), orbukoi (Maasai, Tanzania), and mbarao or mwalambe, in KiswahiliSouthern and central AfricaDiarrhea, stomach pain, gastric ulcer, colic, heartburnGenitourinary infection, urethral pain, endometritis, cystitis, leucorrhea, syphilis, gonorrhea, malaria, dysmenorrhea, nervousness, hysteria, epilepsy, athlete's foot, indigestion, stomach pain, gastric ulcer, colitis, cough, vomiting, hepatitis, jaundice, cirrhosis, yellow fever \[[@CR16]\]T13*T. bursarina*Yellow woodAustralia, South Asia \[[@CR17]\]UnknownT14*T. calamansanai*Phillipine almond, AnarepPhilippines, Southeast AsiaLithontriptic \[[@CR18]\], horticultural plant \[[@CR102]\]T15*T. calcicola*UnknownMadagascar Rain Forest \[[@CR19]\]UnknownT16*T. catappa*Indian almond, umbrella tree, tropical almondChina (Guangdong, Taiwan, SE Yunnan), Australia and SE Asia, Africa, South America Tropical CoastBlood stasis, liver injury \[[@CR20]\]Diarrhea, dysentery, biliary inflammation \[[@CR23]\], dermatitis, hepatitis \[[@CR106]\]T17*T. chebula*Black Mytrobalan, Inknut, Chebulic MyrobalanNepal, northern India, Myanmar, Sri Lanka, Thailand, Bangladesh, China (Yunnan), HimalayanDigestion appetizers, vomiting, infertility, asthma, sore throat, vomiting, urticaria, diarrhea, dysentery, bleeding, ulcers, gout, bladder disease \[[@CR21]\]T18*T. chebula* var. *tomentella*Weimaohezi (variant)China (western Yunnan), MyanmarUnknownT19*T. citrina*Manahei, Yellow myrobalanIndia, Bangladesh \[[@CR22]\]Dysmenorrhea, bleeding, heart disease, dysentery, constipation \[[@CR22]\]T20*T. elliptica*Indian laurelSE Asia, India, Bangladesh, Laos, Myanmar, Nepal, Thailand, Cambodia, VietnamWine, palm sugarUlcers, fractures, bleeding, bronchitis, diarrhea \[[@CR23]\]T21*T. franchetii*DianlanrenSW China \[[@CR24]\]UnknownT22*T. franchetii* var. *membranifolia*Baoyedianlanren (variant)China \[western Guangxi (Longlin), central to SE Yunnan\]UnknownT23*T. franchetii* var. *glabra*Guang yedianlanren (variant)China (Sichuan and Yunnan Jinsha River Basin)UnknownT24*T. ferdinandiana*Gubinge, Bbillygoat plum, Kakadu plum, green plum, salty plum, murunga, madorAustralia \[[@CR25]\]Dietary supplements, skin care \[[@CR25]\]T25*T. glaucescens*UnknownNigeria \[[@CR26]\]Amenorrhea, vaginal infections, syphilis, sores, neurological disordersAnti-plasma, antiparasitic, antiviral, antimicrobial \[[@CR26], [@CR27]\]T26*T. hainanensis*Ji zhenmu, Hainan lanrenChina (Hainan)Antioxidant \[[@CR28]\]T27*T. intricate*CuozhilanrenChina (NW Yunnan and SW Sichuan)UnknownT28*T. ivorensis*Idigbo, Black Afara, Shingle Wood, Brimstone Wood, BlackbarkCameroon, West Africa, Ivory Coast, Liberia, Nigeria, Sierra Leone, GhanaRheumatism, gastroenteritis, psychotic analgesics \[[@CR29]\]Syphilis, burns and bruises \[[@CR30]\]T29*T. kaernbachii*Okari NutSolomon Islands, Papua New Guinea*α*-Glucosidase inhibitor activity \[[@CR31]\]T30*T. kaiserana*UnknownTanzaniaDiarrhea, gonorrhea vomiting \[[@CR44]\]T31*T. laxiflora*UnknownWest Africa, Sudan SavannahMalaria, cough \[[@CR32]\]Fumigant, rheumatic pain, smoothen skin, body relaxation \[[@CR33]\]T32*T. macroptera*BayankadaTropical (West Africa)Wound, hepatitis, malaria, fever, cough, diarrhea, tuberculosis, skin diseases \[[@CR34]\]T33*T. mantaly*UnknownAfrica, MadagascarDysenteryT34*T. mollis*Bush willowAfricaDiarrhea, gonorrhea, malaria, AIDS adjuvant therapy \[[@CR35]\]T35*T. muelleri*Ketapang kencanaIndonesia, SE Asia, South AsiaAntibacterial \[[@CR36]\], antioxidants \[[@CR37]\]T36*T. myriocarpa*QianguolanrenChina \[Guangxi (Longjin), Yunnan (central to the south), and Tibet (Medog)\], northern Vietnam, Thailand, Laos, northern Myanmar, Malaysia, NE India, SikkimAntioxidant, liver protection \[[@CR38]\]T37*T. myriocarpa* var. *hirsuta*Yingmaoqianguolanren (variant)Yunnan, China; ThailandUnknownT38*T. oblongata*Rose wood, yellow woodCentral Queensland \[[@CR39]\]Unknown \[[@CR39]\]T39*T. paniculata*VellamaruthIndiaCholera, mumps, menstrual disorders, cough, bronchitis, heart failure, hepatitis, diabetes, obesity \[[@CR40]\]T40*T. parviflora*Tropical almond, umbrella tree, Indian almondSri Lanka and India \[[@CR41]\]Diarrhea \[[@CR41]\]T41*T. prunioides*Hareri, Sterkbos, Purple pod Terminalia, MwangatiSouthern AfricaPostnatal abdominal painT42*T. sambesiaca*UnknownSouthern AfricaCancer, gastric ulcer, appendicitisBloody diarrhea \[[@CR45]\]T43*T. schimperiana*Idi odanAfrica, Sierra Leone, Guinea, Uganda, EthiopiaLocal burns, bronchitis, dysentery \[[@CR42]\]T44*T. sericea*Monakanakane, Mososo, Mogonono, Amangwe, Vaalboom, Mangwe, Silver clutter-leafNorthern South Africa, Botswana (except central Kalahari), southern Mozambique, Tanzania, Namibia, Zimbabwe, Northern Democratic Republic of Congo, tropical Africa \[[@CR43]\]Diarrhea, sexually transmitted infections, rash, tuberculosis \[[@CR43]\]Fever, high blood pressure \[[@CR44]\]T45*T. spinosa*Musosahwai, spiny cluster leaf, KasansaSouthern AfricaMalaria, fever \[[@CR46]\]Epilepsy, poisoning \[[@CR47]\]T46*T. stenostachya*Rosette leaf TerminaliaSouthern AfricaEpilepsy, poisoning \[[@CR47]\]T47*T. stuhlmannii*UnknownAcacia \[[@CR48]\]UnknownT48*T. superba*LimbaTropical Western AfricaGastroenteritis, diabetes, female infertility, abdominal pain, bacteria/fungi/viral infections \[[@CR49]\], diabetes remedies, anesthetic, hepatitis \[[@CR50]\]T49*T. triflora*Lanza, lanza amarilla, amarillo derío, paloamarilloTropical (South America)Northern and Northwest Argentina \[[@CR149]\]Making posts, furniture, weapons, fuel \[[@CR149]\]T50*T. tropophylla*UnknownMadagascan \[[@CR51]\]Unknown*SE* southeastern, *NE* northeastern, *SW* southwestern, *NW* northwestern

*Terminalia* species are broadly used in many aspects. Some are employed as drugs, while others can provide high quality wood, tannin or dyes. For example, fruits of *T. ferdinandiana*, a species largely distributed in Australia, are rich in vitamin C, and possess strong antioxidant activity \[[@CR25]\]. *T. bellirica* and *T. chebula* are not only recorded in every version of Chinese pharmacopoeia, but are also the important and most commonly applied drugs in Han, Tibetan, Mongolian and many other folk medicinal systems in India, Burma, Thailand, Malaysia, Vietnam and other southeast asian countries. *T. catappa* is a commonly used medicinal plant for liver protection in China \[[@CR20]\].

Chemical Composition {#Sec3}
====================

Since 1930s, the chemical compositions of the genus *Terminalia* have been vastly studied. *T. arjuna*, *T. bellirica*, *T. catappa* and *T. chebula*, having been frequently used in the Ayurvedic, Chinese and Tibetan medicines, attracted scholars' attention. To date, 368 compounds, largely terpenoids (**1--104**), tannins (**105--196**), flavonoids (**197--241**), lignans (**242--265**), phenols and glycosides (**268--318**) were reported from the genus (Tables [2](#Tab2){ref-type="table"}, [3](#Tab3){ref-type="table"}).Table 2Chemical constituents isolated from the genus *Terminalia* and the studied plant organsNo.CompoundsPlantsOrgansReferencesTriterpenes (86) **1**2α,3β,19α-Trihydroxyolean-12-en-20-oic acid 3-*O*-β-[d]{.smallcaps}-galactosyl-(1 → 3)-β-[d]{.smallcaps}-glucosideT1R\[[@CR3]\] **2**2α,3β,19α-Trihydroxyolean-12-en-28-oic acid methylester 3β-*O*-rutinosideT1R\[[@CR53]\] **3**2α,3β,19β,23-Tetrahydroxyolean-12-en-28-oic acid 3β-*O*-β-[d]{.smallcaps}-galactosyl-(1 → 3)-β-[d]{.smallcaps}-glucoside-28-*O*-β-[d]{.smallcaps}-glucosideT1R\[[@CR52]\] **4**3-Acetylmaslinic acidT1RB\[[@CR54]\] **5**Arjunic acidT1T4T17T25T28T32T44BSB, FFSBBBR\[[@CR55], [@CR74]\]\[[@CR60], [@CR79], [@CR124]\]\[[@CR146]\]\[[@CR130]\]\[[@CR132]\]\[[@CR145]\]\[[@CR133]\] **6**Arjunoside IT4SB\[[@CR61]\] **7**Arjunoside IIT4SB\[[@CR61]\] **8**Arjunoside IIIT4R\[[@CR62], [@CR63]\] **9**Arjunoside IVT4R\[[@CR62], [@CR63]\] **10**ArjunetinT1T4T8, T16, T17, T20, T39BB, L, S, R, FB, L, S, R, F\[[@CR55], [@CR74]\]\[[@CR23], [@CR67]\]\[[@CR23]\] **11**Oleanolic acidT1T9T4, T16, T20T8, T17T39T28T36HLB, L, S, R, FB, L, S, RL, S, R, FBB\[[@CR56]\]\[[@CR97]\]\[[@CR23]\]\[[@CR23]\]\[[@CR23]\]\[[@CR132]\]\[[@CR140]\] **12**Ursolic AcidT4, T16, T20T8, T17T39B, L, S, R, FL, S, RB, L, S, F\[[@CR23]\]\[[@CR23]\]\[[@CR23]\] **13**Maslinic acidT1T9T17T36HLFB\[[@CR56]\]\[[@CR97]\]\[[@CR21], [@CR116]\]\[[@CR140]\] **14**2α,3α,24-Trihydroxyolean-11,13(18)-dien-28-oic acidT33SB\[[@CR158]\] **15**Terminoside AT4B\[[@CR58]\] **16**ArjungeninT4T25T12T8, T16, T20, T39T17T25T28T32T33T44SB,L,R,FRBB, L, S, R, FB, L, S, R, FR, SBBBSBRB\[[@CR23], [@CR60], [@CR70], [@CR74]\]\[[@CR60]\]\[[@CR99]\]\[[@CR23]\]\[[@CR23], [@CR146]\]\[[@CR69], [@CR130]\]\[[@CR132]\]\[[@CR145]\]\[[@CR158]\]\[[@CR133], [@CR152]\] **17**Hypatic acidT25R\[[@CR69]\] **18**Arjunglucoside IT4T17T50T32B, RFRB\[[@CR70], [@CR74], [@CR78]\]\[[@CR146]\]\[[@CR72]\]\[[@CR145]\] **19**SericosideT4T25T28T44T32T50BSBBR, L, SBBR\[[@CR71]\]\[[@CR130]\]\[[@CR76], [@CR131]\]\[[@CR43], [@CR133], [@CR149]\]\[[@CR145]\]\[[@CR72]\] **20**CrataegiosideT4T17BF\[[@CR75]\]\[[@CR146]\] **21**23-*O*-neochebuloylarjungenin 28-*O*-β-[d]{.smallcaps}-glycosyl esterT17F\[[@CR146]\] **22**23-*O*-4′-*epi*-neochebuloylarjungeninT17F\[[@CR146]\] **23**23-*O*-galloylarjunic acidT39T32BB\[[@CR144]\]\[[@CR145]\]T17F\[[@CR146]\] **24**Quercotriterpenoside IT32B\[[@CR145]\]T17F\[[@CR146]\] **25**Sericic acidT28T32T44BBR\[[@CR132]\]\[[@CR145]\]\[[@CR150]\] **26**24-Deoxy-sericosideT32B\[[@CR138]\] **27**Arjunolic acidT1T4T7T9T8T16, T17, T20, T39T34T36B, HB, H, L, S, R, FRBLB, L, S, RB, L, S, R, FLB\[[@CR55], [@CR56], [@CR74]\]\[[@CR23], [@CR77], [@CR78], [@CR91]\]\[[@CR97]\]\[[@CR23]\]\[[@CR23]\]\[[@CR23], [@CR144]\]\[[@CR35]\]\[[@CR140]\] **28**Terminolic acidT1T17T7, T16, T31T25T32HFHH, RlH, B\[[@CR56]\]\[[@CR146]\]\[[@CR128]\]\[[@CR128]\]\[[@CR128], [@CR145]\] **29**Arjunglucoside IIT4T17BF\[[@CR70], [@CR74]\]\[[@CR146]\] **30**23-*O*-galloylarjunolic acidT17F\[[@CR146]\] **31**23-*O*-galloylarjunolic acid 28-*O*-β-[d]{.smallcaps}-glucosyl esterT17F\[[@CR146]\] **32**23-*O*-galloylterminolic acid 28-*O*-β-[d]{.smallcaps}-glucosyl esterT17F\[[@CR146]\] **33**ArjunolitinT4SB\[[@CR80]\] **34**TerminolitinT4F\[[@CR80]\] **35**Arjunglucoside IIIT4B\[[@CR74]\] **36**Methyl oleanateT4R, F\[[@CR80], [@CR124]\] **37**Olean-3α,22β-diol-12 en-28-oic acid 3-*O*-β-[d]{.smallcaps}-glucosyl-(1 → 4)-β-[d]{.smallcaps}-glucosideT4B\[[@CR81], [@CR84]\] **38**ArjunetosideT4R, SB\[[@CR82]\] **39**Olean 3β,6β,22α-triol-12en-28-oic acid-3-*O*-β-[d]{.smallcaps}-glucosyl-(1 → 4)-β-[d]{.smallcaps}-glucosideT4B\[[@CR84]\] **40**2α,19α,Dihydroxy-3-oxo-olean-12-en-28-oic acid-28-*O*-β-[d]{.smallcaps}-glucosideT4R\[[@CR85]\] **41**Ivorengenin A (2α,19α,24-trihydroxy-3-oxoolean-12-en-28-oic acid)T28B\[[@CR132]\] **42**Chebuloside IT17F\[[@CR115]\] **43**Chebuloside IIT17T32FB\[[@CR115]\]\[[@CR138]\] **44**ArjunglucosideT17T44T33FR, SBSB\[[@CR115]\]\[[@CR133]\]\[[@CR158]\] **45**Glaucescic acid (2α,3α,6α,23-tetrahydroxyolean-2-en-28-oic acid)T25R\[[@CR69]\] **46**Glaucinoic acid (2α,3β,19α,24-tetrahydroxyolean-12-en-30-oic acid)T25SB\[[@CR130]\] **47**Termiarjunoside I (olean-1α,3β,9α,22α-tetraol-12-en-28-oic acid-3-β-[d]{.smallcaps}-glucoside)T4SB\[[@CR156]\] **48**Termiarjunoside II (olean-3α,5α,25-triol-12-en-23,28-dioic acid-3α-[d]{.smallcaps}-glucoside)T4SB\[[@CR156]\] **49**β-AmyrinT25T36SBB\[[@CR129]\]\[[@CR140]\] **50**Ivorenoside AT28B\[[@CR131]\] **51**Ivorenoside BT28B\[[@CR131]\] **52**Ivorenoside CT28B\[[@CR131]\] **53**Ivorengenin B (4-oxo-19α-hydroxy-3,24-dinor-2,4-secoolean-12-ene-2,28-dioic acid)T28B\[[@CR132]\] **54**1α,3β-Hydroxyimberbic acid 23-*O*-α-[l]{.smallcaps}-4-acetylrhamnosideT47SB\[[@CR48]\] **55**1α,3β,3,23-Trihydroxy-olean-12-en-29-oate-23-*O*-α-\[4-acetoxyrhamnosyl\]-29-α-rhamnosideT47SB\[[@CR48]\] **56**2α,3β-Dihydroxyolean-12-en-28-oic acid 28-*O*-β-[d]{.smallcaps}-glucosideT48SB\[[@CR49]\] **57**2α,3β,21β-Trihydroxyolean-12-en-28-oic acid 28-*O*-β-[d]{.smallcaps}-glucosideT48SB\[[@CR49]\] **58**2α,3β,29-Trihydroxyolean-12-en-28-oic acid 28-*O*-β-[d]{.smallcaps}-glucosideT48SB\[[@CR49]\] **59**2α,3β,23,27-Tetrahydroxyolean-12-en-28-oic acid 28-*O*-β-[d]{.smallcaps}-glucosideT48SB\[[@CR49]\] **60**Terminaliaside A ((3β,21β,22α)-3-*O*-(3′-*O*-angeloylglucosyl)-21,22-dihydroxy-28-*O*-sophorosyl-16-oxoolean-12-ene)T50R\[[@CR72]\] **61**2, 3, 23-Trihydroxylolean-12-eneT7RB\[[@CR91]\] **62**2α,3β,23-Trihydroxylolean-12-en-28-oic acidT48SB\[[@CR49]\] **63**23-*O*-galloylpinfaenoic acid 28-*O*-β-[d]{.smallcaps}-glucosyl esterT17F\[[@CR146]\] **64**Pinfaenoic acid 28-*O*-β-[d]{.smallcaps}-glucosyl esterT4T17BF\[[@CR76]\]\[[@CR146]\] **65**2α,3β-Dihydroxyurs-12,18-dien-28-oic acid 28-*O*-β-[d]{.smallcaps}-glucosyl esterT4B\[[@CR76]\] **66**Quadranoside VIIIT4B\[[@CR76]\] **67**Kajiichigoside F1T4B\[[@CR76]\] **68**2α,3β,23Trihydroxyurs-12,19-dien-28-oic acid 28-*O*-β-[d]{.smallcaps}-glucosyl esterT4B\[[@CR76]\] **69**α-AmyrinT7RB\[[@CR91]\] **70**2α,3β,23-Trihydroxy-urs-12-en-28-oic acidT34L\[[@CR35]\] **71**2α-Hydroxyursolic acidT34T17LF\[[@CR35]\]\[[@CR115], [@CR116]\] **72**Ursolic acidT11L\[[@CR35]\] **73**2α-Hydroxymicromeric acidT17F\[[@CR115], [@CR116]\] **74**Betulinic acidT1T11T12T4, T16, T17, T20, T39T8T25T28T36BLBB, L, S, R, FB, L, S, RSBBB\[[@CR55]\]\[[@CR35]\]\[[@CR99]\]\[[@CR23]\]\[[@CR23]\]\[[@CR129]\]\[[@CR132]\]\[[@CR140]\] **75**Terminic acidT4R, H\[[@CR57], [@CR62]\] **76**LupeolT4T25T44SBSBSB, R\[[@CR80]\]\[[@CR129]\]\[[@CR43]\] **77**Monogynol AT12B\[[@CR99]\] **78**TriterpenesT25T44SBR, SB\[[@CR129]\]\[[@CR133]\] **79**FriedelinT4T7T25T34FRBSBSB\[[@CR83]\]\[[@CR93]\]\[[@CR129], [@CR130]\]\[[@CR35]\] **80**Maslinic lactoneT1H\[[@CR56]\] **81**Terminalin AT25SB\[[@CR129]\] **82**Arjunaside AT4B\[[@CR68]\] **83**Arjunaside BT4B\[[@CR68]\] **84**Arjunaside CT4B\[[@CR68]\] **85**Arjunaside DT4B\[[@CR68]\]**86**Arjunaside ET4B\[[@CR68]\]Mono- (14) and sesqui- (4) terpendoids **87**α-PineneT9L\[[@CR13]\] **88**SabineneT9L\[[@CR13]\] **89**MyrceneT9L\[[@CR13]\] **90**β-PineneT9L\[[@CR13]\] **91**1,8-CineoleT9L\[[@CR13]\] **92**LinaloolT9L\[[@CR13]\] **93**MenthoneT9L\[[@CR13]\] **94**γ-TerpineolT9L\[[@CR13]\] **95**α-TerpineolT9L\[[@CR13]\] **96**LimoneneT9L\[[@CR13]\] **97**NeralT9L\[[@CR13]\] **98**GeraniolT9L\[[@CR13]\] **99**ThymolT9L\[[@CR13]\] **100**IsomenthoneT9L\[[@CR13]\] **101**β-CopaeneT9L\[[@CR13]\] **102**β-CaryophylleneT9L\[[@CR13]\] **103**CaryophylleneT9L\[[@CR13]\] **104**α-HumuleneT9L\[[@CR13]\]Hydrolysable (89) and condensed tannins (2) **105**1,2,3,6-Tetra-*O*-galloyl-β-[d]{.smallcaps}-glucoseT17F\[[@CR159]\] **106**Gallotannin (1,2,3,4,6 penta galloyl glucose)T4T17T19T30T45, T46SB, LFFRL\[[@CR86]\]\[[@CR21], [@CR118], [@CR119]\]\[[@CR120]\]\[[@CR133]\]\[[@CR133]\] **107**1,3,4,6-Tetra-*O*-galloyl-β-[d]{.smallcaps}-glucoseT17F\[[@CR159]\] **108**2,3,4,6-Tetra-*O*-galloyl-[d]{.smallcaps}-glucoseT3T4FSB, L\[[@CR154]\]\[[@CR86]\] **109**1,2,6-Tri-*O*-galloyl-β-[d]{.smallcaps}-glucoseT31R\[[@CR101]\] **110**Sanguiin H-1T14L\[[@CR102]\] **111**1,6-Di-*O*-galloyl-β-[d]{.smallcaps}-glucoseT3T17T40FFB\[[@CR154]\]\[[@CR21], [@CR119]\]\[[@CR41]\] **112**1,3,6-Tri-*O*-galloyl-β-[d]{.smallcaps}-glucoseT3T40T19T17FBFF\[[@CR154]\]\[[@CR41]\]\[[@CR120]\]\[[@CR159]\] **113**Methyl 3,6-di-*O*-galloyl-β-[d]{.smallcaps}-glucosideT40B\[[@CR41]\] **114**4,6 Bis hexahydroxydiphenyl-1-galloyl-glucoseT4SB, L\[[@CR86]\] **115**Sanguiin H-4T14 L\[[@CR18], [@CR102]\] **116**CorilaginT3T31T16T17T19T24T32FRL, BFFFL\[[@CR154]\]\[[@CR101]\]\[[@CR41], [@CR106], [@CR107]\]\[[@CR21], [@CR118], [@CR119], [@CR159]\]\[[@CR120]\]\[[@CR126]\]\[[@CR135], [@CR136]\] **117**TercatainT16T17B, LF\[[@CR41], [@CR106], [@CR107]\]\[[@CR159]\] **118**1,3-Di-*O*-galloyl-β-[d]{.smallcaps}-glucoseT17F\[[@CR159]\] **119**2,3-*O*-(*S*)-HHDP-[d]{.smallcaps}-glucoseT3T14T4T16T40T36FLBB, LBL\[[@CR154]\]\[[@CR102]\]\[[@CR104]\]\[[@CR41], [@CR107]\]\[[@CR41]\]\[[@CR38]\] **120**2,3-(*S*)-HHDP-6-*O*-galloyl-[d]{.smallcaps}-glucoseT3T4T40T32FBBB\[[@CR154]\]\[[@CR104]\]\[[@CR41]\]\[[@CR137]\] **121**3,6-Di-*O*-galloyl-[d]{.smallcaps}-glucoseT3T40T17FBF\[[@CR154]\]\[[@CR41]\]\[[@CR159]\] **122**3,4-Di-*O*-galloyl-[d]{.smallcaps}-glucoseT3F\[[@CR154]\] **123**6-*O*-galloyl-[d]{.smallcaps}-glucoseT17F\[[@CR159]\] **124**3,4,6-Tri-*O*-galloyl-[d]{.smallcaps}-glucoseT17F\[[@CR159]\] **125**Tellimagrandin IT35T17LF\[[@CR139]\]\[[@CR159]\] **126**Gemin DT17F\[[@CR159]\] **127**ArjuninT4T17LF\[[@CR65], [@CR86]\]\[[@CR115]\] **128**PunicalinT3T4T14T40T16T17T28T49FL, BLBLL, FSBL\[[@CR154]\]\[[@CR65], [@CR86], [@CR104]\]\[[@CR102]\]\[[@CR41]\]\[[@CR106], [@CR107]\]\[[@CR21], [@CR155]\]\[[@CR29]\]\[[@CR149]\] **129**CasuarininT4T16T17L, BBF\[[@CR88], [@CR104]\]\[[@CR41]\]\[[@CR21], [@CR118], [@CR119]\] **130**CasuariinT4B\[[@CR90], [@CR104]\] **131**TerchebulinT3T4T7T12T17T31FBSBBFW\[[@CR154]\]\[[@CR90], [@CR104]\]\[[@CR92]\]\[[@CR100]\]\[[@CR21]\]\[[@CR134]\] **132**CastalaginT4T16, T40BB\[[@CR90], [@CR104]\]\[[@CR41]\] **133**GrandininT16, T40B\[[@CR41]\] **134**CastalinT16, T40B\[[@CR41]\] **135**α/β-PunicalaginT3T7T4T11T12T31T14T16T17T40T19T28T32T35T36T38FSBBLBRLBL, FBFSBBLLL\[[@CR154]\]\[[@CR92]\]\[[@CR104]\]\[[@CR35]\]\[[@CR100]\]\[[@CR101]\]\[[@CR18], [@CR103]\]\[[@CR41]\]\[[@CR21], [@CR106], [@CR119], [@CR155]\]\[[@CR41]\]\[[@CR120]\]\[[@CR29]\]\[[@CR137]\]\[[@CR139]\]\[[@CR38]\]\[[@CR39]\] **136**1-α-*O*-galloylpunicalaginT14 L\[[@CR18], [@CR102], [@CR103]\] **137**6′-*O*-methyl neochebulagateT17F\[[@CR159]\] **138**Dimethyl neochebulagateT17F\[[@CR159]\] **139**Neochebulagic acidT17F\[[@CR159]\] **140**Dimethyl 4′-epi-neochebulagateT17F\[[@CR159]\] **141**Methyl chebulagateT17F\[[@CR159]\] **142**Chebulagic acidT3T4T8T17T16T39T20T19T32T35FB, L, SF, B, L, SF, B, L, S, RF, B, L, S, RF, B, L, S, RF, B, L, RFLL\[[@CR154]\]\[[@CR23]\]\[[@CR23]\]\[[@CR23], [@CR96]\]\[[@CR3], [@CR4], [@CR9], [@CR21], [@CR110]\]\[[@CR23]\]\[[@CR23]\]\[[@CR120]\]\[[@CR135], [@CR136]\]\[[@CR139]\] **143**Chebulinic acidT3T4, T8, T16, T20, T39T17T32T35FF, B, L, S, RF, B, L, S, RLL\[[@CR154]\]\[[@CR23]\]\[[@CR3], [@CR4], [@CR21], [@CR110], [@CR119], [@CR155]\]\[[@CR23]\]\[[@CR110], [@CR135], [@CR139]\] **144**ChebulaninT34, T11T17LF\[[@CR35]\]\[[@CR21], [@CR119], [@CR155], [@CR159]\] **145**1,3-Di-*O*-galloyl-2,4-chebuloyl-β-[d]{.smallcaps}-glucoseT3F\[[@CR154]\] **146**1,6-Di-*O*-galloyl-2,4-chebuloyl-β-[d]{.smallcaps}-glucoseT17F\[[@CR155], [@CR159]\] **147**2-*O*-galloylpunicalinT14T40T32T49LBBL\[[@CR18]\]\[[@CR41]\]\[[@CR137]\]\[[@CR149]\] **148**1-DesgalloyleugeniinT14T16LL\[[@CR102]\]\[[@CR107]\] **149**EugeniinT14 L\[[@CR102]\] **150**Rugosin AT14 L\[[@CR102]\] **151**1(α)-*O*-galloylpedunculaginT14 L\[[@CR102]\] **152**Praecoxin AT14 L\[[@CR102]\] **153**CalamansaninT14 L\[[@CR102]\] **154**Calamanin AT14 L\[[@CR102]\] **155**Calamanin BT14 L\[[@CR102]\] **156**Calamanin CT14 L\[[@CR102]\] **157**Terflavin CT4T14T17BLL\[[@CR104]\]\[[@CR103]\]\[[@CR21]\] **158**Terflavin AT16T17T32LFB\[[@CR106], [@CR107]\]\[[@CR21]\]\[[@CR137]\] **159**Terflavin BT16T17T32LL, FB\[[@CR106], [@CR107]\]\[[@CR21], [@CR155]\]\[[@CR137]\] **160**3-Methoxy-4-hydroxyphenol-1-*O*-β-[d]{.smallcaps}-(6′-*O*-galloyl)-glucosideT16B\[[@CR41]\] **161**3,5-Di-methoxy-4-hydroxyphenol-1-*O*-β-[d]{.smallcaps}-(6′-*O*-galloyl)-glucosideT16B\[[@CR41]\] **162**Acutissimin AT16B\[[@CR41]\] **163**Eugenigrandin AT16B\[[@CR41]\] **164**Catappanin AT16B\[[@CR41]\] **165**CastamollininT40B\[[@CR41]\] **166**TergallaginT16L\[[@CR106], [@CR107]\] **167**GeraniinT16L\[[@CR107]\] **168**Granatin BT16L\[[@CR107]\] **169**Gallotannic (tannic acid)T17,T8T38FL\[[@CR113]\]\[[@CR141]\] **170**ChebulinT17F\[[@CR113], [@CR114]\] **171**TerchebinT17F\[[@CR113], [@CR119]\] **172**Neochebulinic acidT3T17FF\[[@CR154]\]\[[@CR21], [@CR119], [@CR155]\] **173**Chebumeinin AT17F\[[@CR118]\] **174**Chebumeinin BT17F\[[@CR118]\] **175**IsoterchebulinT32B\[[@CR137]\] **176**Punicacortein CT3T32T17FBF\[[@CR154]\]\[[@CR137]\]\[[@CR159]\] **177**Punicacortein DT17F\[[@CR159]\] **178**4,6-*O*-Isoterchebuloyl-[d]{.smallcaps}-glucoseT32B\[[@CR137]\] **179**Trigalloyl-β-[d]{.smallcaps}-glucoseT35L\[[@CR139]\] **180**Tetragalloyl-β-[d]{.smallcaps}-glucoseT35L\[[@CR139]\] **181**Pentagalloyl-β-[d]{.smallcaps}-glucoseT35L\[[@CR139]\] **182**1,2,3-Tri-*O*-galloyl-6-*O*-cinnamoyl-β-[d]{.smallcaps}-glucoseT17F\[[@CR159]\] **183**1,2,3,6-Tetra-*O*-galloyl-4-*O*-cinnamoyl-β-[d]{.smallcaps}-glucoseT17F\[[@CR159]\] **184**1,6-Di-*O*-galloyl-2-*O*-cinnamoyl-β-[d]{.smallcaps}-glucoseT17F\[[@CR159]\] **185**1,2-Di-*O*-galloyl-6-*O*-cinnamoyl-β-[d]{.smallcaps}-glucoseT17F\[[@CR159]\] **186**4-*O*-(2′′, 4′′-di-*O*-galloyl-α-[l]{.smallcaps}-rhamnosyl) ellagic acidT17F\[[@CR159]\] **187**4-*O*-(4′′-*O*-galloyl-α-[l]{.smallcaps}-rhamnosyl) ellagic acidT17F\[[@CR159]\] **188**4-*O*-(3′′, 4′′-di-*O*-galloyl-α-[l]{.smallcaps}-rhamnosyl) ellagic acidT17F\[[@CR159]\] **189**1′-*O*-methyl neochebulaninT17F\[[@CR159]\] **190**Dimethyl neochebulinateT17F\[[@CR159]\] **191**Phyllanemblinin ET17F\[[@CR159]\] **192**1′-*O*-methyl neochebulinateT17F\[[@CR159]\] **193**Phyllanemblinin FT17F\[[@CR159]\] **194**Procyanidin B-1T16B\[[@CR41]\] **195**3′-*O*-galloyl procyanidin B-2T16B\[[@CR41]\]Flavonoids (45) **196**5,7,2′-Tri-*O*-methylflavanone4′-*O*-α-l-rhamnosyl-(1 → 4)-β-[d]{.smallcaps}-glucosideT1R\[[@CR52]\] **197**ArjunoneT4B, F\[[@CR83], [@CR89]\] **198**8-Methyl-5,7,2′,4′-tetramethoxy-flavanone T1T39RB\[[@CR53]\]\[[@CR144]\] **199**NaringinT4T8T17T39T20L, S, FB, FL, R, FR, FB, L, S, R\[[@CR23]\]\[[@CR23]\]\[[@CR23]\]\[[@CR23]\]\[[@CR23]\] **200**EriodictyolT4, T8, T17, T20, T39T16B, L, S, R, FL, S, R, F\[[@CR23]\]\[[@CR23]\] **201**HesperitinT24F\[[@CR122]\] **202**FlavanoneT24F\[[@CR122]\] **203**Arjunolone (6,4-dihydroxy-7-methoxy flavone)T4SB\[[@CR64]\] **204**Bicalein (5,6,7-trihydroxy flavone)T4SB\[[@CR64]\] **205**ScutellareinT4T8, T17, T20T16T39B, RB, L, S, R, FL, FB, L, R, F\[[@CR23]\]\[[@CR23]\]\[[@CR23]\]\[[@CR23]\] **206**LuteolinT4T8, T20T17T16T39T24B, LL, SR, LLL, S, FF\[[@CR23], [@CR65]\]\[[@CR23]\]\[[@CR23]\]\[[@CR23]\]\[[@CR23]\]\[[@CR122]\] **207**ApigeninT4T8, T16, T17, T20, T39B, L, S, R, FB, L, S, R, F\[[@CR23], [@CR66]\]\[[@CR23]\] **208**IsoorientinT11T4, T8, T17, T16, T20, T39T35T36LB, L, S, R, FLL\[[@CR35]\]\[[@CR23]\]\[[@CR139]\]\[[@CR38]\] **209**OrientinT11T4T8T17T16T39T20T35T36LL, FB, SB, L, S, R, FL, R, FB, S, FL, S, F, RLL\[[@CR35]\]\[[@CR23]\]\[[@CR23]\]\[[@CR23]\]\[[@CR23]\]\[[@CR23]\]\[[@CR23]\]\[[@CR139]\]\[[@CR38]\] **210**IsovitexinT11T4T17T16T39T20T35T36LL, FL, R, FLS, FL, S, FLL\[[@CR35]\]\[[@CR23]\]\[[@CR23]\]\[[@CR23], [@CR105]\]\[[@CR23]\]\[[@CR23]\]\[[@CR139]\]\[[@CR38]\] **211**Apigenin-6-C-(2″-*O*-galloyl)-β-[d]{.smallcaps}-glucosideT16L[@CR105]\] **212**Apigenin-8-C-(2″-*O*-galloyl)-β-[d]{.smallcaps}-glucosideT16T34LL\[[@CR105]\]\[[@CR35]\] **213**VitexinT4, T17, T20T8T16T39T35T36B, L, S, R, FB, L, S, RL, S, R, FB, L, S, FLL\[[@CR23]\]\[[@CR23]\]\[[@CR23]\]\[[@CR23]\]\[[@CR139]\]\[[@CR38]\] **214**AmentoflavoneT8T17T20L, SL, R, FL\[[@CR23]\]\[[@CR23]\]\[[@CR23]\] **215**NeosaponarinT36L\[[@CR38]\] **216**(−)-EpicatechinT4B\[[@CR76]\] **217**Epicatechin T4, T8, T17, T20, T39T16T34B, L, S, R, FL, S, R, FSB\[[@CR23]\]\[[@CR23]\]\[[@CR35]\] **218**CatechinT34T11T4, T8, T16, T17, T20, T39T44SBLB, L, S, R, FR\[[@CR35]\]\[[@CR35]\]\[[@CR23]\]\[[@CR133]\] **219**Catechin--epicatechinT44R\[[@CR43]\] **220**Catechin--epigallocatechinT44R\[[@CR43]\] **221**EpigallocatechinT34SB\[[@CR35]\] **222**(−)-Epicatechin-3-*O*-gallateT16B\[[@CR41]\] **223**(−)-Epigallocatechin-3-*O*-gallateT16B\[[@CR41]\] **224**FlavanolT24F\[[@CR122]\] **225**GallocatechinT34T24SBF\[[@CR35]\]\[[@CR126]\] **226**QuercetinT4T8T17T16T39T20T24T49B, L, RRS, R, FL, S, FL, BFFL\[[@CR23]\]\[[@CR23]\]\[[@CR23]\]\[[@CR23]\]\[[@CR23], [@CR142]\]\[[@CR23]\]\[[@CR124]\]\[[@CR124]\] **227**KaempferolT4T8T16, T17T20, T39T24B, L, S, R, FB, L, S, FB, L, S, R, FL, S, R, FF\[[@CR23], [@CR66]\]\[[@CR23]\]\[[@CR23]\]\[[@CR23]\]\[[@CR122]\] **228**Kaempferol-3-*O*-β-[d]{.smallcaps}-rutinosideT4, T8, T17T16T39T20T36B, L, S, R, FL, S, FL, R, FL, S, RL\[[@CR23]\]\[[@CR23]\]\[[@CR23]\]\[[@CR23]\]\[[@CR38]\] **229**Afzelin (kaempferol 3-*O*-rhamnoside)T49L\[[@CR124]\] **230**RutinT4, T16T8T17, T39T20T32T36B, L, S, FL, SB, L, S, R, FL, S, FLL\[[@CR23]\]\[[@CR23]\]\[[@CR23]\]\[[@CR23]\]\[[@CR135], [@CR136]\]\[[@CR38]\] **231**NarcissinT32L\[[@CR135], [@CR136]\] **232**Quercetin-3,4′-di-*O*-glucosideT4T8T16, T17, T20, T39B, L, S, FB, S, FB, L, S, R, F\[[@CR23]\]\[[@CR23]\]\[[@CR23]\] **233**Quercetin-7-*O*-rhamnosideT4F\[[@CR80]\] **234**2-*O*-β-glucosyloxy-4,6,2′,4′-tetramethoxychalconeT1R\[[@CR53]\] **235**CerasidinT4F\[[@CR80]\] **236**GenisteinT4T8, T16, T17, T20, T39B, L, S, R, FB, L, S, R, F\[[@CR23], [@CR80]\]\[[@CR23]\] **237**CyanidingT4B\[[@CR66]\] **238**PelargonidinT4B\[[@CR66]\] **239**LeucocyanidinT4B\[[@CR80]\] **240**7-Hydroxy-3′,4-(methylenedioxy)flavanT8FR\[[@CR12]\]Lignan (27) **241**TermilignanT8T39FRB\[[@CR12]\]\[[@CR144]\] **242**Anolignan BT8T44FRR\[[@CR12]\]\[[@CR43], [@CR151]\] **243**ThannilignanT8FR\[[@CR12]\] **244**Termilignan BT44R\[[@CR133]\] **245**Ferulic acid dehydrodimerT24F\[[@CR125]\] **246**(7*S*,8*R*,7′*R*,8′*S*)-4′-hydroxy-4-methoxy-7,7′-epoxylignanT48SB\[[@CR50]\] **247**Meso-(rel7*S*,8*R*,7′*R*,8′*S*)-4,4′-dimethoxy-7,7′-epoxylignanT48SB\[[@CR50]\] **248**4′-*O*-cinnamoyl cleomiscosin AT50R\[[@CR72]\] **249**Diethylstilbestrol monosulphateT24F\[[@CR126]\] **250**Terminaloside AT19L\[[@CR22]\] **251**Terminaloside BT19L\[[@CR22]\] **252**Terminaloside CT19L\[[@CR22]\] **253**Terminaloside DT19L\[[@CR22]\] **254**Terminaloside ET19L\[[@CR22]\] **255**Terminaloside FT19L\[[@CR22]\] **256**Terminaloside GT19L\[[@CR22]\] **257**Terminaloside HT19L\[[@CR22]\] **258**Terminaloside IT19L\[[@CR22]\] **259**Terminaloside JT19L\[[@CR22]\] **260**Terminaloside KT19L\[[@CR22]\] **261**2-Epiterminaloside DT19L\[[@CR22]\] **262**6-Epiterminaloside KT19L\[[@CR22]\] **263**Terminaloside LT19L\[[@CR121]\] **264**Terminaloside MT19L\[[@CR121]\] **265**Terminaloside NT19L\[[@CR121]\] **266**Terminaloside OT19L\[[@CR121]\] **267**Terminaloside PT19L\[[@CR121]\]Phenols and glycosides (52) **268**Ellagic acidT1T7T10, TM, TTT12T40T4, T8, T20T17T16T39T24T25T31T28, T32T35T42T30, T44T36, T45, T46T48T49BSBSBBBB, L, S, R, FL, SB, R FSB, L, R, FB, L, S, R, F, HFB, R, RlBHL, FR, SBRLSBL\[[@CR55]\]\[[@CR92], [@CR127]\]\[[@CR14]\]\[[@CR100]\]\[[@CR41]\]\[[@CR23], [@CR80], [@CR83], [@CR86]\]\[[@CR3], [@CR9], [@CR21], [@CR23], [@CR111], [@CR119]\]\[[@CR14], [@CR23], [@CR41], [@CR108], [@CR144]\]\[[@CR23], [@CR142]\]\[[@CR123]\]\[[@CR70], [@CR127], [@CR128]\]\[[@CR127], [@CR134]\]\[[@CR128]\]\[[@CR37], [@CR38]\]\[[@CR133]\]\[[@CR133]\]\[[@CR133]\]\[[@CR50]\]\[[@CR124]\] **269**Methyl ellagic acidT4B\[[@CR90]\] **270**3-*O*-methylellagic acidT33SB\[[@CR158]\] **271**3,3′-Di-*O*-methylellagic acidT28T39T48SBH,BSB\[[@CR29]\]\[[@CR8], [@CR9], [@CR143], [@CR144]\]\[[@CR50]\] **272**3,3′-Di-*O*-methylellagic acid 4-mono glucosideT39H\[[@CR147], [@CR148]\] **273**Tetra-*O*-methyl ellagic acidT39H\[[@CR148]\] **274**3,3′-Di-*O*-methylellagic acid 4-*O*-β-[d]{.smallcaps}-glucosyl-(1 → 4)-β-[d]{.smallcaps}-glucosyl-(1 → 2)-α-[l]{.smallcaps}-arabinosideT1R\[[@CR52]\] **275**3,4,3′-Tri-*O*-methylflavellagic acidT7T12T24T25T31T28T32T39BBFL, B, R, RlBSB, HH, BH\[[@CR126]\]\[[@CR100]\]\[[@CR126]\]\[[@CR26], [@CR70], [@CR127], [@CR128]\]\[[@CR127]\]\[[@CR29], [@CR128]\]\[[@CR128], [@CR138]\]\[[@CR143], [@CR148]\] **276**3,3′,4-*O*-trimethyl-4′-*O*-β-[d]{.smallcaps}-glucosylellagic acidT28SB\[[@CR29]\] **277**3,3′-Di-*O*-methyl ellagic acid 4′-*O*-β-[d]{.smallcaps}-xylosideT48SB\[[@CR50]\] **278**3,4′-Di-*O*-methylellagic acid 3′-*O*-β-[d]{.smallcaps}-xylosideT48SB\[[@CR153]\] **279**4′-*O*-galloy-3,3′-di-*O*-methylellagic acid 4-*O*-β-[d]{.smallcaps}-xylosideT48SB\[[@CR153]\] **280**Flavogallonic acidT7T40T31T12T36SBBWRL\[[@CR92]\]\[[@CR41]\]\[[@CR134]\]\[[@CR101]\]\[[@CR38]\] **281**Methyl (*S*)-flavogallonateT36L\[[@CR38]\] **282**Vanillic acid 4-*O*-β-[d]{.smallcaps}-(6′-*O*-galloyl) glucosideT32B\[[@CR138]\] **283**3-*O*-methylellagic acid 4′-*O*-α-[l]{.smallcaps}-rhamnosideT4T34T33BSBSB\[[@CR76]\]\[[@CR35]\]\[[@CR158]\] **284**Eschweilenol C (ellagic acid 4-*O*-α-[l]{.smallcaps}-rhamnoside)T12T17BF\[[@CR100]\]\[[@CR164]\] **285**3-*O*-methylellagic acid 4′-*O*-xylosideT31R\[[@CR101]\] **286**Brevifolincarboxylic acidT35L\[[@CR139]\]T17F\[[@CR159]\] **287**Terflavin DT17L\[[@CR21]\] **288**Gallic acidT3T4, T8, T20, T39T10, TM, TTT17T16T34T12T31T40T24T30T35T36T38T42T44T45, T46T48T49FB, L, S, R, FSBSB, F, R, LSB, F, R, LLBR, WBFRLLLR, SBRLSBL\[[@CR154]\]\[[@CR23], [@CR80], [@CR83], [@CR86]\]\[[@CR14]\]\[[@CR14], [@CR21], [@CR23], [@CR118], [@CR119]\]\[[@CR14], [@CR23], [@CR41], [@CR108]\]\[[@CR35]\]\[[@CR100]\]\[[@CR101], [@CR134]\]\[[@CR41]\]\[[@CR123], [@CR125]\]\[[@CR133]\]\[[@CR139]\]\[[@CR38]\]\[[@CR141]\]\[[@CR133]\]\[[@CR133]\]\[[@CR133]\]\[[@CR50]\]\[[@CR124]\]**289**Phyllemblin (ethyl gallate isomers1 progallin A)T4T8T24T28T36BFFSBL\[[@CR86]\]\[[@CR96], [@CR113]\]\[[@CR126]\]\[[@CR29]\]\[[@CR38]\]**290**Monogalloyl glucoseT3T8T17T31FFFR\[[@CR154]\]\[[@CR113]\]\[[@CR21]\]\[[@CR101]\] **291**Methyl gallateT14T8T32T36T48T49LFLLSBL\[[@CR18]\]\[[@CR113]\]\[[@CR135], [@CR136]\]\[[@CR38]\]\[[@CR50]\]\[[@CR124]\] **292**Shikimic acidT32L\[[@CR135], [@CR136]\] **293**5-*O*-galloyl-(−)-shikimic acidT3T17FF\[[@CR118]\]\[[@CR154], [@CR159]\] **294**4-*O*-galloyl-(−)-shikimic acidT17F\[[@CR159]\] **295**3,5-Di-*O*-galloyl-(−)-shikimic acidT3F\[[@CR154]\] **296**Digallic acidT17F\[[@CR159]\] **297**Ethyl gallate isomers2T24F\[[@CR126]\] **298**Ethyl gallate isomers3T24F\[[@CR126]\] **299**Dimethyl gallic acidT35L\[[@CR139]\] **300**Chebulic acidT3T17T24T35FFFL\[[@CR154]\]\[[@CR4], [@CR9], [@CR112], [@CR119], [@CR159]\]\[[@CR125], [@CR126]\]\[[@CR139]\] **301**6′-*O*-methyl chebulateT17F\[[@CR159]\] **302**7′-*O*-methyl chebulateT17F\[[@CR159]\] **303**Chebulic acid trimethyl esterT32L\[[@CR135], [@CR136]\] **304**Terminalin*T38*L\[[@CR39]\] **305**Decarboxyellagic acidT3F\[[@CR154]\] **306**3-*O*-galloyl-[d]{.smallcaps}-glucoseT3F\[[@CR154]\] **307**6-*O*-galloyl-[d]{.smallcaps}-glucoseT3T17FF\[[@CR154]\]\[[@CR159]\] **308**Vanillic acidT4, T8, T20, T39T17T16T44B, L, S, R, FBS, R, B, FR\[[@CR23]\]\[[@CR23], [@CR117]\]\[[@CR23]\]\[[@CR43]\] **309**Benzoic acidT44T24RF\[[@CR43]\]\[[@CR122]\] **310**Hydrocinnamic acidT44R\[[@CR43]\] **311**Gentisic acidT16L\[[@CR108]\] **312**Protocatechuic acidT4, T8, T16, T17, T20, T39B, L, S, R, F\[[@CR23]\] **313**2,3-Di-hydroxyphenyl β-[d]{.smallcaps}-glucosiduronic acidT24F\[[@CR125]\] **314**Quinic acidT4, T8, T16, T17, T20, T39T24B, L, S, R, F\[[@CR23]\]\[[@CR125]\] **315***p*-Coumaric acidT17T44WPR\[[@CR117]\]\[[@CR43]\] **316**Caffeic acidT4, T8T17T16T39T20T44L, SL, S, RLB, L, S, R, FBR\[[@CR23]\]\[[@CR23]\]\[[@CR23]\]\[[@CR23]\]\[[@CR23]\]\[[@CR43]\] **317**Chlorogenic acidT4T17T16, T39T20L, SS, R, F, LLB\[[@CR23]\]\[[@CR23]\]\[[@CR23]\]\[[@CR23]\] **318**Ferulic acidT4T8, T17, T20, T39T16B, L, S, FB, L, S, R, FL, S, R\[[@CR23]\]\[[@CR23]\]\[[@CR23]\] **319**Sinapic acidT4, T16, T20, T39T8T17B, L, S, R, FS, R, FB, S, R, F\[[@CR23]\]\[[@CR23]\]\[[@CR23]\]Steroids (8), polyols (9) and esters (6) **320**β-SitosterolT1T4T8T12T16T48T25T36T39T44B, HS, FFFB, SBHHSBBH, SB, R\[[@CR55], [@CR56]\]\[[@CR57], [@CR83]\]\[[@CR96], [@CR113]\]\[[@CR99]\]\[[@CR128]\]\[[@CR128]\]\[[@CR129]\]\[[@CR140]\]\[[@CR147], [@CR148]\]\[[@CR43], [@CR133], [@CR152]\] **321**β-Sitosterol-3-acetateT44SB, R\[[@CR43]\] **322**β-Sitosteryl palmitateT16T25, T31SB, HL,F\[[@CR128]\]\[[@CR128]\] **323**Stigmasterol 3-*O*-β-[d]{.smallcaps}-glucosideT4T33FSB\[[@CR80]\]\[[@CR158]\] **324**StigmasterolT12T25T33T44BSBSBRB\[[@CR99]\]\[[@CR129]\]\[[@CR158]\]\[[@CR133], [@CR152]\] **325**Stigma-4-ene-3-oneT44RB\[[@CR43]\] **326**16,17-Dihydroneridienone 3*O*-β-[d]{.smallcaps}-glucosyl-(1 → 6)-*O*-β-[d]{.smallcaps}-galactosideT4R\[[@CR59]\] **327**Cannogenol 3-*O*-β-[d]{.smallcaps}-galactosyl-(1 → 4)-*O*-α-[l]{.smallcaps}-rhamno-sideT8Se\[[@CR94]\] **328**2-HexanolT9L\[[@CR13]\] **329**OctanolT9L\[[@CR13]\] **330**Methoxycarbonyloxymethyl methylcarbonateT24F\[[@CR125]\] **331**RibonolactoneT24F\[[@CR125]\] **332**Apionic acidT24F\[[@CR125]\] **333**Ascorbic acidT24F\[[@CR125]\] **334**GluconolactoneT24F\[[@CR125]\] **335**Glucohepatonic acid-1,4-lactoneT24F\[[@CR125]\] **336**Galacturonic acidT44R\[[@CR43]\] **337**Geranyl formateT9L\[[@CR13]\] **338**Citronellyl acetateT9L\[[@CR13]\] **339**Geranyl acetateT9L\[[@CR13]\] **340**Geranyl tiglateT9L\[[@CR13]\] **341**LaxiflorinT31RB\[[@CR127]\] **342**(1*S*,5*R*)-4-oxo-6,8-dioxabicyclo\[3.2.1\]oct-2-ene-2-carboxylic acidT24F\[[@CR125]\]Others (26) **343**Glucuronic acidT24F\[[@CR125]\] **344**CoumarinT45L\[[@CR133]\] **345**Eujavonic acidT24F\[[@CR125]\] **346**PurineT24F\[[@CR125]\] **347**5-(4-Hydroxy-2,5-dimethylphenoxy)-2,2-dimethylpentanoic acid (gemfibrozil M1)T24F\[[@CR125]\] **348***p*-Hydroxytiaprofenic acidT24F\[[@CR125]\] **349***Cis*-polyisopreneT32L\[[@CR135]\] **350**Arachidic acidT17F\[[@CR113]\] **351**Behenic acidT8, T17F\[[@CR113]\] **352**ArjunaphthanolosideT4SB\[[@CR87]\] **353**Resveratrol (3′,4,5′-trihydroxystilbene)T24T44FR\[[@CR126]\]\[[@CR43]\] **354**Resveratrol glucoside (piceid)T24T44FRB[@CR126]\]\[[@CR152]\] **355**Resveratrol-β-[d]{.smallcaps}-glucosideT44RB\[[@CR152]\] **356**CombretastatinT24F\[[@CR126]\] **357**Combretastatin A1T24F\[[@CR126]\] **358**(*Z*)-StilbeneT44R\[[@CR133]\] **359**(*E*)-StilbeneT44R\[[@CR133]\] **360**3′5′-Dihydroxy-4-(2-hydroxyethoxy) resveratrol-3-*O*-β-rutinosideT44R, RB\[[@CR43], [@CR152]\] **361**Resveratrol-3-β-rutinoside glycosideT44R, RB\[[@CR43], [@CR152]\] **362**1,4-CineoleT9L\[[@CR13]\] **363**Terpinen-4-olT9L\[[@CR13]\] **364**TerminalianoneT12B\[[@CR98]\] **365**Termicalcicolanone AT15WP\[[@CR19]\] **366**Termicalcicolanone BT15WP\[[@CR19]\] **367**MangiferinT4T8T17T16T39T20B, S, FB, R, FB, L, S, R, FL, R, FB, L, S, FL, S, R\[[@CR23]\]\[[@CR23]\]\[[@CR23]\]\[[@CR23]\]\[[@CR23]\]\[[@CR23]\] **368**Benzoyl-β-[d]{.smallcaps}-(4′ → 10″geranilanoxy)-pyranosideT8F\[[@CR160]\]*R* root, *SB* stem bark, *B* bark, *F* fruit, *S* stem, *H* heartwood, *RB* root bark, *Rl* rootlet, *Se* seed, *FR* fruit rind, *WP* whole plant, *T1*--*T50* plants from Table [1](#Tab1){ref-type="table"}, *TM T. manii*, *TT T. tomentosa*Table 3The numbers and main types of compounds reported from different *Terminalia* speciesNo.PlantPlant organsNumbersMain typesT1*T. alata*Roots, barks18TriterpenesT3*T. arborea*Fruits24Hydrolysable tanninT4*T. arjuna*Whole plants93Triterpenes, tannins, flavonoidsT7*T. avicennioides*Barks10Triterpenes, tanninsT8*T. bellirica*Fruits, barks45Triterpenes, flavonoids, lignin, simple phenolsT9*T. bentzoe*Leaves29Monoterpenoids, sesquiterpenoidT11*T. brachystemma*Leaves8FlavonoidsT12*T. brownii*Leaves13TriterpenesT14*T. calamansanai*Leaves18Hydrolysable tanninT16*T. catappa*Whole plants64Triterpenes, tannins, flavonoids, simple phenolsT17*T. chebula*Whole plants120Triterpenes, tannins, flavonoids, simple phenolsT19*T. citrina*Fruits, leaves23LignanT20*T. elliptica*Whole plants36FlavonoidsT24*T. ferdinandiana*Fruits35Flavonoids, simple phenols, polyolsT25*T. glaucescens*Barks19TriterpenesT28*T. ivorensis*Barks18TriterpenesT31*T. laxiflora*Roots13TanninsT32*T. macroptera*Whole plants28Triterpenes, tannins, simple phenolsT33*T. mantaly*Stem barks7Triterpenes, simple phenolsT34*T. mollis*Barks12Triterpenes, flavonoidsT35*T. muelleri*Leaves16Hydrolysable tannin, flavonoids, simple phenolsT36*T. myriocarpa*Leaves, barks21Triterpenes, flavonoids, simple phenolsT39*T. paniculata*Barks43Triterpenes, flavonoids, simple phenolsT40*T. parviflora*Barks16TanninsT44*T. sericea*Roots32Triterpenes, simple phenols, other compoundsT48*T. superba*Barks15Triterpenes, simple phenolsChemical components identified from the other 12 species, including *T. bialata* (T10), *T. calcicola* (T15), *T. kaiserana* (T30), *T. manii* (TM), *T. macroptera* (T32), *T. oblongata* (T38), *T. sambesiaca* (T42), *T. spinosa* (T45), *T. stenostachya* (T46), *T. stuhlmannii* (T47), *T. triflora* (T49), *T. tropophylla* (T50) were less than 6 compounds

Terpenoids {#Sec4}
----------

So far, 104 terpenoids (Fig. [1](#Fig1){ref-type="fig"}) including 86 triterpenes (**1--86**), 14 monoterpenes (**87--100**), 4 sesquiterpenes (**101--104**) have been reported from the genus *Terminalia*. The triterpenoids are mainly oleanane, ursane and lupine types, and their glycosides. Particularly, Atta-ur-Rahman et al. isolated a new *seco*-triterpene terminalin A (**81**) possessing a novel rearranged *seco*-glutinane structure with a pyran ring-A and an isopropanol moiety from the stem barks of *T. glaucescens* \[[@CR129]\]. Ponou et al. found two dimeric triterpenoid glucosides, ivorenosides A and B (**49--50**) possessing an unusual skeleton \[[@CR131]\], and two new oleanane type triterpenes, 3-oxo-type ivorengenin A (**41**) and 3,24-dinor-2,4-secooleanane-type ivorengenin B (**53**) from the barks of *T. ivorensis* \[[@CR132]\]. Compounds **41**, **49** and **53** showed significant anticancer activities. Wang et al. isolated five new 18,19-secooleanane type triterpene glycosyl esters, namely arjunasides A--E (**82--86**) from the MeOH extract of *T. arjuna*'*s* barks, TaBs \[[@CR68]\]. Moreover, five ursane type triterpene glucosyl esters (**64--68**) were also obtained for the first time \[[@CR76]\]. From the fruits of *T. chebula*, 23-*O*-neochebuloylarjungenin 28-*O*-β-[d]{.smallcaps}-glycosyl ester (**21**) and 23-*O*-4′-*epi*-neochebuloylarjungenin (**22**) with novel substituents at C-23 were reported, in addition to compounds **23--24**, **30--32** and **63**, whose C-23 substituents were gallate. Compounds **30** and **31** had strong hypoglycemic effect \[[@CR146]\]. Furthermore, compound **40** was obtained from the barks of *T. arjuna* \[[@CR85]\], while friedelin (**79**) with 3-oxo moiety was reported from the fruits of *T. arjuna* \[[@CR83]\], the root barks of *T. avicennioides* \[[@CR93]\], and the stem barks of *T. glaucescens* \[[@CR130]\] and *T. mollis* \[[@CR35]\].Fig. 1The structures of terpenoids **1--104**

Tannins {#Sec5}
-------

As the main secondary metabolites, 91 tannins (**105--195**) were reported from the genus *Terminalia* (Fig. [2](#Fig2){ref-type="fig"}), including ellagitannins, gallotannins, dimeric, and trimeric tannins. Four cinnamoyl-containing gallotannins (**182--185**) were discovered firstly from the fruits of *T. chebula*, and 1,2,3,6-tetra-*O*-galloyl-4-*O*-cinnamoyl-β-[d]{.smallcaps}-glucose (**183**) and 4-*O*-(2″,4″-di-*O*-galloyl-α-[l]{.smallcaps}-rhamnosyl) ellagic acid (**186**) showed significant inhibitory activity on α-glucosidase with IC~50~ values of 2.9 and 6.4 μM, respectively \[[@CR159]\].Fig. 2The structures of tannins **105--195**

Tannins possess not only liver and kidney protection properties, but also anti-diarrhea, anticancer, antibacterial and hypoglycemic activities \[[@CR133]\]. However, a condensed tannin terminalin (**186**) from *T. oblongata* was reported to have severe hepatorenal toxicity and even caused renal necrosis \[[@CR39]\].

Flavonoids {#Sec6}
----------

The *Terminalia* genus are rich in flavonoids (Fig. [3](#Fig3){ref-type="fig"}) comprising of flavanones (**196--202**), flavones (**203--215**), flavan-3-ols (**216--225**), and flavonols (**226--233**). Among them, cerasidin (**235**) of chalcone, genistein (**236**) of isoflavone, and leucocyanidin (**239**) of flavan-3,4-diol from *T. arjuna* \[[@CR80]\] were described as rare structural types in the *Terminalia* genus. Moreover, a new chalcone glycoside 2-*O*-β-glucosyloxy-4,6,2′,4′-tetramethoxychalchone (**234**) was reported from the roots of *T. alata* \[[@CR53]\]. In addition, anthocyanidin cyanidin (**237**) and pelargonidin (**238**), flavanoid 7-hydroxy-3′,4-(methylenedioxy)flavan (**240**) and other structure were reported \[[@CR12], [@CR23], [@CR66]\]. Compounds **209--213**, **215** were *C*-glycosides at C-6 or C-8 of ring A.Fig. 3The structures of flavonoids **197--240**

Lignans {#Sec7}
-------

Twenty-seven lignans (**241--267**) were reported from the genus *Terminalia* (Fig. [4](#Fig4){ref-type="fig"}). A new lignan 4′-*O*-cinnamoyl cleomiscosin A (**248**) was reported from the ethanol extract of *T. tropophylla* roots \[[@CR72]\]. Moreover, 13 new furofuran lignan glucosides, terminalosides A--K (**250--260**), 2-epiterminaloside D (**261**), 6-epiterminaloside K (**262**) and 5 new polyalkoxylated furofuranone lignan glucosides, terminalosides L--P (**263--267**) were obtained from the leaves of *T. citrina*. All of them were tested for their estrogenic and/or antiestrogenic activities using estrogen responsive breast cancer cell lines T47D and MCF-7, and showed varying degrees of inhibitory activity. Among them, terminalosides B (**251**), G (**256**), L (**263**) and M (**264**) inhibited cell growth by up to 90% at a minimum concentration of 10 nM \[[@CR22], [@CR121]\].Fig. 4The structures of lignans **241--267**

Phenols and Glycosides {#Sec8}
----------------------

There are 52 phenols and glycosides reported in the *Terminalia* genus (Fig. [5](#Fig5){ref-type="fig"}), in which ellagic acid (**268**) and gallic acid (**289**) are present in almost all species. Studies have shown that most of the simple phenolic compounds have antioxidant, antibacterial, hypoglycemic, liver and kidney protection \[[@CR23]\].Fig. 5The structures of phenols and glycosides (**268--319**)

Sterols and Cardiac Glycosides {#Sec9}
------------------------------

Only 6 sterols (**320--325**) and 2 cardiac glycosides (**326-327**) were isolated from the genus *Terminalia* before 2001 (Fig. [6](#Fig6){ref-type="fig"}).Fig. 6The structures of steroids (**320--325**) and cardiac glycosides (**326--327**)

Polyols and Esters {#Sec10}
------------------

Polyols and lipids were reported to be abundant in the genus *Terminalia* and concentrated mainly in fruits and leaves \[[@CR125]\]. So far, 9 polyol (**328--336**) and 6 esters (**337--342**) have been documented (Fig. [7](#Fig7){ref-type="fig"}).Fig. 7The structures of polyols and esters (**328--342**)

Other Compounds {#Sec11}
---------------

Other compounds featured in the *Terminalia* genus are shown in Fig. [8](#Fig8){ref-type="fig"} and are mostly styrenes. Cao et al. isolated two new cytotoxic xanthones - termicalcicolanone A (**365**), termicalcicolanone B (**366**) in *T. calcicola*, and found an inhibitory effect on ovarian cancer \[[@CR19]\]. Hiroko Negishi et al. obtained a new chromone derivative - terminalianone (**364**) from the barks of *Terminalia brownii* \[[@CR98]\]. Ansari et al. isolated the novel compound, 4′-substituted benzoyl-β-[d]{.smallcaps} glycoside (**368**), from the fruits of *T. bellirica* and illustrated its potential for anticoagulation \[[@CR160]\].Fig. 8The structures of other compounds (**343--368**)

Moreover, chlorophyll and various vitamins were reported from the genus *Terminalia*.

Pharmacological Activities {#Sec12}
==========================

The pharmacological activities of the genus *Terminalia*, mainly including antimicrobial, antioxidant, cytotoxicity, anti-inflammatory, hypoglycemic, cardiovascular, mosquitocidal and antiviral, have been extensively studied.

Antimicrobial {#Sec13}
-------------

Extracts of several *Terminalia* species exhibit antimicrobial activity against various microbes. For example, methanol and aqueous extracts of *T. australis* were demonstrated antimicrobial activity against *Ca. albicans* (MIC = 180 and 250 µg/mL, resp.) and *Ca. kruzzei* (MIC = 250 and 300 µg/mL, resp.) \[[@CR8]\]. Aqueous extracts of the stem barks, woods and whole roots of *T. brownii* showed antibacterial activity against standard strains of *Sta. aureus* (14.0 ± 1.1 µg/mL), *Escherichia coli*, *Ps. aeruginosa* (12.0 ± 1.1 µg/mL), *Klebsiella pneumonia* (6.0 ± 1.0 µg/mL), *Sa. typhi* and *Bacillus anthracis* (13.0 ± 1.0 µg/mL), as well as fungi *Ca. albicans* (12.3 ± 1.5 µg/mL) and *Cr. neoformans* (9.7 ± 1.1 µg/mL) \[[@CR16]\]. Ethanol extracts of the root barks and leaves of *T. schimperiana* were against *Sta. aureus*, *Ps. aeruginosa* and *Sa. typhi* (MIC = 0.058--2.089 mg/mL), with inhibition zone diameters (IZDs) of 17.2 to 10.0 mm, compared to gentamicin (IZD = 21.8--10 mm). The results supported the efficacy of the extracts in the folkloric treatment of burns wounds, bronchitis and dysentery, respectively \[[@CR42]\]. Antibacterial tests on *Mycobacterium smegmatis* ATCC 14468 showed that methanol extract of *T. sambesiaca* roots and stem barks had promising effects (MIC = 1.25 mg/mL, both) \[[@CR133]\].

Ellagitannin punicalagin (**133**) obtained from the stem barks of *T. mollis* demonstrated crucial activity against *Ca. parapsilosis* and *Ca. krusei* (MIC = 6.25 μg/mL), as well as *Ca. albicans* (MIC = 12.5 μg/mL) \[[@CR35]\]. 7-Hydroxy-3′,4′-(methylenedioxy) flavan (**240**), termilignan (**241**), anolignan B (**242**) and thannilignan (**243**) isolated from the fruit rinds of *T. bellirica* displayed significant antifungal activity against *Penicillium expansum* (MIC = 1.0, 2.0, 3.0 and 4.0 µg/mL, resp.), also with **240** and **241** against *Ca. albicans* at 10 and 6 µg/mL, resp. \[[@CR12]\]. The antimycobacterial activity of friedelin (**79**) furnished from the root barks of *T. avicennioides* was 4.9 μg/mL in terms of MIC value \[[@CR93]\]. *β*-Arjungenin (**16**), betulinic acid (**74**), sitosterol (**319**) and stigmasterol (**323**) from *T. brownii* were proved to possess antibacterial activity, with **74** the most active against *A. niger* and *S. ipomoea* (MIC = 50 μg/ml) \[[@CR99]\].

Antioxidant {#Sec14}
-----------

*Terminalia* species have also illustrated some interesting antioxidant properties \[[@CR161]\]. By a 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay, relatively high anti-oxidant activities of the methanol extracts of *T. alata*, *T. bellirica* and *T. corticosa* trunk-barks were found (IC~50~ = 0.24, 1.02 and 0.25 mg/mL, resp.), compared to the positive control, [l]{.smallcaps}-ascorbic acid (IC~50~ = 0.24 mg/mL) \[[@CR2]\].

Flavonoid glycosides, apigenin-6-*C*- (**211**) and apigenin-8-*C*- (**212**) (2″-*O*-galloy1)-*β*-[d]{.smallcaps}-glucoside, isolated from dried fallen leaves of *T. catappa*, showed significant antioxidative effects (IC~50~ = 2.1 and 4.5 µM, resp.) on Cu^2+^/0^2^-induced low density lipoprotein lipid peroxidation, with probucol (IC~50~ = 4.0 µM) as positive control \[[@CR105]\].

Arjunaphthanoloside (**351**), isolated from the stem barks of *T. arjuna* showed potent antioxidant activity and inhibited nitric oxide (NO) production in lipopolysaccharide (LPS)-stimulated rat peritoneal macrophages \[[@CR87]\], while ivorenosides B (**51**) and C (**52**), two triterpenoid saponins from *T. ivorensis*, exhibited scavenging activities against DPPH and ABTS^+^ radicals \[[@CR131]\].

The antioxidant potential of *T. paniculata* (TPW) was investigated by DPPH, ABTS^2−^, NO, superoxide (O^2−^), Fe^2+^ chelating and ferric reducing/antioxidant power (FRAP) assays. TPW showed maximum superoxide, ABTS^2−^, NO, DPPH inhibition, and Fe^2+^-chelating property at 400 µg/mL, resp. FRAP value was 4.5 ± 0.25 µg Fe(II)/g, which demonstrated the efficacy of aqueous barks extract of *T. paniculata* as a potential antioxidant and analgesic agent \[[@CR142]\].

TaB contains various natural antioxidants and has been used to protect animal cells against oxidative stress. The alleviating effect of TaB aqueous extract against Ni toxicity in rice (*Oryza sativa* L.) suggested that TaB extract considerably alleviated Ni toxicity in rice seedlings by preventing Ni uptake and reducing oxidative stress in the seedlings \[[@CR162]\]. Behavioral paradigms and PCR studies of TaB extract against picrotoxin-induced anxiety showed that TaB supplementation increased locomotion towards open arm (EPM), illuminated area (light--dark box test), and increased rearing frequency (open field test) in a dose dependent manner, compared to picrotoxin (P \< 0.05). Furthermore, alcoholic extract of TaB showed protective activity against picrotoxin in mice by modulation of genes related to synaptic plasticity, neurotransmitters, and antioxidant enzymes \[[@CR174]\].

Cytotoxicity {#Sec15}
------------

70% Acetone extracts of *T. calamansanai* leaves inhibited the viability of human promyelocytic leukemia HL-60 cells. Sanguiin H-4 (**115**), 1-*α*-*O*-galloylpunicalagin (**136**), punicalagin (**135**), 2-*O*-galloylpunicalin (**147**) and methyl gallate (**290**) were the main components isolated from *T. calamansanai* with the IC~50~ values of 65.2, 74.8, 42.2, 38.0 and \> 100 µM, respectively, for HL-60 cells. Apoptosis of HL-60 cells treated with 1-*α*-*O*-galloylpunicalagin, **115**, **135**, and **147** was noted by the appearance of a sub-G1 peak in flow cytometric analysis and DNA fragmentation by gel electrophoresis. **115** and **147** induced a decrease of the human poly (ADP-ribose) polymerase (PARP) cleavage-related procaspase-3 and elevated activity of caspase-3 in HL-60 cells, but not normal human peripheral blood mononuclear cells, PBMCs \[[@CR18]\].

Terminaliaside A (**60**), an oleanane-type triterpenoid saponin isolated from the roots of *T. tropophylla* showed antiproliferative activity against the A2780 human ovarian cancer cell line with an IC~50~ value of 1.2 µM \[[@CR72]\]. The 70% methanolic extract of *T. chebula* fruits was found to decrease cell viability, inhibit cell proliferation, and induce cell death of human (MCF-7) and mouse (S115) breast cancer, human osteosarcoma (HOS-1), human prostate cancer (PC-3) and a non-tumorigenic, immortalized human prostate (PNT1A) cell lines. Flow cytometry and other analyses showed that some apoptosis was induced by the extract at lower concentrations, but at higher concentrations, necrosis was the major mechanism of cell death. Chebulinic acid (**143**) and ellagic acid (**186**) were tested by ATP assay on HOS-1 cell line in comparison with three known antigrowth phenolics of *Terminalia*, gallic acid (**287**), methyl gallate (**290**), luteolin (**206**), and tannic acid (**169**). Results showed that the most growth inhibitory phenolics in *T. chebula* fruits were chebulinic acid (IC~50~ = 53.2 µM ±/0.16) \>/tannic acid (IC~50~ = 59.0 mg/mL ±/0.19) \> ellagic acid (IC~50~ = 78.5 µM ±/0.24) \[[@CR111]\].

Aqueous and ethanolic extracts of *T. citrina* fruits were revealed to exhibit significant mutagenicity in tested strains of baby hamster kidney cell line (BHK-21). Ethanolic extract showed higher mutagenicity in TA 100 strain, whereas aqueous extract exhibited higher mutagenicity in TA 102 strain than TA 100. Both extracts showed dose-dependent mutagenicity. Fifty percent cell viability was exhibited by 260 and 545 μg/mL of ethanolic and aqueous extracts respectively \[[@CR169]\]. Moreover, ivorenoside A (**50**) showed antiproliferative activity against MDA-MB-231 and HCT116 human cancer cell lines with IC~50~ values of 3.96 and 3.43 µM, respectively \[[@CR131]\].

Anti-inflammatory {#Sec16}
-----------------

Inflammation has been considered as a major risk factor for various kinds of human diseases. Macrophages play substantial roles in host defense against infection. It can be activated by LPS, the major component of the outer membrane of Gram-negative bacteria. An investigation was carried out to determine anti-inflammatory potential of ethyl acetate fraction isolated from *T. bellirica* (EFTB) in LPS stimulated RAW 264.7 macrophage cell lines. EFTB (100 μg/mL) inhibited all inflammatory markers in dose dependent manner. Moreover, EFTB down regulated the mRNA expression of TNF-α, IL-6, COX-2 and NF-κB against LPS stimulation. These results demonstrated that EFTB is able to attenuate inflammatory response possibly via suppression of ROS and NO species, inhibiting the production of arachidonic acid metabolites, proinflammatory mediators and cytokines release \[[@CR165]\].

Anolignan B (**242**) isolated from roots of *T. sericea* was tested for anti-inflammatory activity using the cyclooxygenase enzyme assays (COX-1 and COX-2) It showed activity against both COX-1 (IC~50~ = 1.5 mM) and COX-2 (IC~50~ = 7.5 mM) enzymes \[[@CR151]\]. Termiarjunosides I (**47**) and II (**48**) isolated from stem barks of *T. arjuna* inhibited aggregation of platelets and suppressed the release of NO and superoxide from macrophages \[[@CR156]\].

The anti-inflammatory activities of a polyphenol-rich fraction (TMEF) obtained from *T. muelleri* was assessed using carrageenan-induced paw edema model by measuring PGE2, TNF-α, IL-1b, and IL-6 plasma levels as well as the paw thickness. The group treated with 400 mg/kg of TMEF showed a greater inhibition in the number of writhes (by 63%) than the standard treated group (61%). TMEF pretreatment reduced the edema thickness by 48, 53, and 62% at the tested doses, respectively. TMEF administration inhibited the carrageenan-induced elevations in PGE2 (by 34, 43, and 47%), TNF-α (18, 28, and 41%), IL-1β (14, 22, and 29%), and IL-6 (26, 31, and 46%) \[[@CR166]\].

Hypoglycemic {#Sec17}
------------

Some species and isolates from *Terminalia* have indicated possession of α-glucosidase inhibitory capabilities. Gallic acid (**287**) and methyl gallate (**290**), from stem barks of *T. superba*, showed significant activity (IC~50~ = 5.2 ± 0.2 and 11.5 ± 0.1 μM, resp.). Arjunic acid (**5**) and glaucinoic acid (**46**) from stem barks of *T. glaucescens* showed significant *β*-glucuronidase inhibitory activity with IC~50~ value 80.1 and 500 μM, resp., against *β*-glucuronidase \[[@CR130]\].

In a study to investigate *α*-glucosidase inhibition of extracts and isolated compounds from *T. macroptera* leaves, chebulagic acid (**142**) showed an IC~50~ value of 0.05 µM towards *α*-glucosidase and 24.9 ± 0.4 µM towards 15-lipoxygenase (15-LO), in contrast to positive controls (acarbose: IC~50~ = 201 ± 28 µM towards *α*-glucosidase, quercetin: IC~50~ = 93 ± 3 µM towards 15-LO). Corilagin (**116**) and narcissin (**231**) were good 15-LO and *α*-glucosidase inhibitors. Rutin (**230**) was a good *α*-glucosidase inhibitor (IC~50~ ca. 3 µM), but less active towards 15-LO \[[@CR136]\].

From the fruits of *T. chebula*, 23-*O*-galloylarjunolic acid (**30**) and 23-*O*-galloylarjunolic acid 28-*O*-*β*-[d]{.smallcaps}-glucosyl ester (**31**) were afforded and showed potent inhibitory activities with IC~50~ values of 21.7 (**30**) and 64.2 (**31**) µM, resp., against Baker's yeast *α*-glucosidase, compared to the positive control, acarbose (IC~50~ 174.0 µM) \[[@CR146]\].

Hydrolyzable tannins, 1,2,3,6-tetra-*O*-galloyl-4-*O*-cinnamoyl-*β*-[d]{.smallcaps}-glucose (**183**) and 4-*O*-(2″,4″-di-*O*-galloyl-α-[l]{.smallcaps}-rhamnosyl) ellagic acid (**186**) from the fruits of *T. chebula*, showed significant *α*-glucosidase inhibitory activities with IC~50~ values of 2.9 and 6.4 µM, resp. In addition, inhibition kinetic studies showed that both compounds have mixed-type inhibitory activities with the inhibition constants (Ki) of 1.9 and 4.0 µM, respectively \[[@CR159]\].

Cardiovascular {#Sec18}
--------------

A few species of *Terminalia* have demonstrated cardiovascular activities. It was reported that the barks of *T. arjuna* possessed significant inotropic and hypotensive effect, mild diuretic, antithrombotic, prostaglandin E2 enhancing and hypolipidaemic activities \[[@CR66]\].

Ethanolic extract of *T. pallida* fruits (TpFE) were studied to determine their cardioprotection against isoproterenol (ISO)-administered rats. The supplementation of TpFE dose-dependently exerts notable protection on myocardium by virtue of its strong antioxidant activity. It could be used as a medicinal food for the treatment of cardiovascular ailments \[[@CR163]\].

Mosquitocidal {#Sec19}
-------------

Insect-borne diseases remain to this day a major source of illness and can cause death worldwide. The resistance to chemical insecticides among mosquito species has been a major problem in vector control. The larvicidal and ovicidal activities of crude benzene, hexane, ethyl acetate, chloroform and methanol extracts of *T. chebula* were tested for their toxicity against three important vector mosquitoes, viz., *Anopheles stephensi*, *Aedes aegypti* and *Culex quinquefasciatus*. All extracts showed moderate larvicidal effects, the highest larval mortality was found in the methanol extract of *T. chebula* against the larvae of *A. stephensi*, *A. aegypti*, and *C. quinquefasciatus* with the LC~50~ values of 87.13, 93.24 and 111.98 ppm, respectively. Mean percent hatchability of the ovicidal activity was observed 48 h post treatment. All the five solvent extracts showed moderate ovicidal activity. The maximum egg mortality (zero hatchability) was observed in the methanol extract of *T. chebula* at 200 and 250 ppm against *A. stephensi*, while *A. aegypti* and *C. quinquefasciatus* showed 100% mortality at 300 ppm. No mortality was observed in the control group. The finding of the investigation revealed that the leaf extract of *T. chebula* possesses remarkable larvicidal and ovicidal activity against medically important vector mosquitoes \[[@CR167], [@CR168]\].

Antiviral {#Sec20}
---------

Termilignan (**241**) and anolignan B (**242**), obtained from *T. bellirica* exhibited antimalarial activity against the chloroquine-susceptible strain 3D7 of *Plasmodium falciparum* (IC~50~ = 9.6 ± 1.2 μM)\[[@CR12]\]. Casuarinin (**129**), chebulagic acid (**142**) from the fruits of *T. chebula* possessed hepatitis C virus inhibition activities (IC~50~ = 9.6 and 5.2 μM, resp.) \[[@CR118]\]. Punicalin (**128**) and 2-*O*-galloylpunicalin (**147**), isolated from aqueous extract of *T. triflora* leaves, showed inhibitory activity on HIV-1 reverse transcriptase with IC~50~ of 0.11 μg/mL (0.14 μM) and 0.10 μg/mL (0.11 μM), resp. \[[@CR149]\].

In vitro anti-HIV-1 activity of acetone and methanol extracts of *T. paniculata* fruits was studied by Durge A. et al. Cytotoxicity tests were conducted on TZM-bl cells and PBMCs, the CC~50~ values of both extracts were ≥ 260 μg/mL. By using TZM-bl cells, the extracts were tested for their ability to inhibit replication of two primary isolates HIV-1 (X4, Subtype D) and HIV-1 (R5, Subtype C). The activity against HIV-1 primary isolate (R5, Subtype C) was confirmed by using activated PBMC and quantification of HIV-1 p24 antigen. Both the extracts showed anti-HIV-1 activity in a dose-dependent manner. The EC~50~ values of the acetone and methanol extracts of *T. paniculata* were ≤ 10.3 μg/mL. Furthermore, the enzymatic assays were performed to determine the mechanism of action which indicated that the anti-HIV-1 activity might be due to inhibition of reverse transcriptase (≥ 77.7% inhibition) and protease (≥ 69.9% inhibition) enzymes \[[@CR172]\].

Kesharwani A. et al. investigated anti-HSV-2 activity of *T. chebula* extract and its constituents, chebulagic acid (**142**) and chebulinic acid (**143**). Cytotoxicity assay using Vero cells revealed CC~50~ = 409.71 ± 47.70 μg/mL for the extract whereas **142** and **143** showed more than 95% cell viability up to 200 μg/mL. The extract from *T. chebula* (IC~50~ = 0.01 ± 0.0002 μg/mL), chebulagic (IC~50~ = 1.41 ± 0.51 μg/mL) and chebulinic acids (IC~50~ = 0.06 ± 0.002 μg/mL) showed dose dependent in vitro anti-viral activity against HSV-2, which can also effectively prevent the attachment and penetration of the HSV-2 to Vero cells. In comparison, acyclovir showed poor direct anti-viral activity and failed to significantly (p \> 0.05) prevent the attachment as well as penetration of HSV-2 to Vero cells when tested up to 50 μg/mL. Besides, in post-infection plaque reduction assay, *T. chebula* extract, chebulagic and chebulinic acids showed IC~50~ values of 50.06 ± 6.12, 31.84 ± 2.64, and 8.69 ± 2.09 μg/mL, resp., which were much lower than acyclovir (71.80 ± 19.95 μg/mL) \[[@CR173]\].

Others {#Sec21}
------

*Terminalia* species were also reported to be used in the treatment of diarrhea \[[@CR95]\], Alzheimer's disease \[[@CR112]\], psoriasis \[[@CR164]\], liver disease \[[@CR170]\], kidney disease \[[@CR171]\], etc. Terminalosides A--K (**249--259**) from the leaves of the Bangladeshi medicinal plant *T. citrina* possess estrogen-inhibitory properties. Among them, Terminaloside E (**253**) showed inhibitory activity against the T47D cell line, such terminalosides C (**252**), F (**255**), and I (**258**). Besides, 6-epiterminaloside K (**262**) displayed antiestrogenic activity against MCF-7 cells \[[@CR22]\].

Conclusion and Future Prospects {#Sec22}
===============================

The genus *Terminalia* contains not only a large number of tannins, simple phenolics, but also a lot of terpenoids, flavonoids, lignans and other compounds. Most tannins, simple phenolics and flavonoids have antioxidation, antibacterial, antiinflammatory and anticancer activities. The plants of the genus *Terminalia* have exhibited positive effect on immune regulation, cardiovascular disease and diabetes, and can accelerate wound healing \[[@CR157]\]. Therefore, the *Terminalia* genus has great medicinal potential. However, most of the chemical composition of species is still unknown, we should use modern advanced technology such as LC--MS to continue to isolate its compounds, and determine their pharmacological activities and mechanism of action, to explore other possible greater medicinal value.
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